Gohealth, Inc. Stock Price, News & Analysis

GoHealth (NASDAQ: GOCO) reported third-quarter 2025 results on November 13, 2025, describing a deliberate pullback in Medicare Advantage volume to prioritize member quality, retention, and platform efficiency. The company said it conserved liquidity, reduced fixed cost, and preserved core retention and agent-enablement capabilities while maintaining leadership in Special Needs Plans.

GoHealth also stated it secured a superpriority term loan facility, received covenant relief, and refreshed its board to retain strategic flexibility for potential integration and consolidation as the Medicare Advantage market rationalizes.

GoHealth (NASDAQ: GOCO) announced it will release third quarter 2025 financial results on the morning of November 13, 2025. CEO Vijay Kotte and CFO Brendan Shanahan will host a conference call and live audio webcast at 8:00 a.m. ET the same day to discuss the results.

The live audio webcast will be available on GoHealth's Investor Relations website at https://investors.gohealth.com/, and a replay will be posted for on-demand listening shortly after the call.

GoHealth (NASDAQ: GOCO) said it is deploying proprietary tools to help Medicare consumers through the 2026 Annual Enrollment Period (Oct 15–Dec 7) amid significant market disruption. The company highlighted its PlanFit reviews and PlanGPT AI assistant to improve plan comparisons, support licensed agents, and cut call times.

GoHealth cited industry headwinds—about 2 million Medicare Advantage plan exits and 10 million plan degradations—plus risks of smaller networks, reduced supplemental benefits, and higher copays. The company reported nearly 30,000 PlanFit confirmations last AEP and said its AI tools cut average call time by 10 minutes in 2024.

GoHealth Inc. (NASDAQ: GOCO) reported challenging Q2 2025 results, with net revenues declining 11.2% year-over-year to $94.0M. The company experienced significant decreases in partner revenue (-44.4%) and non-agency revenue (-79.4%), partially offset by growth in GoHealth Protect segment.

The company secured $115M in new and rolled-up loans and amended its credit agreement to waive near-term principal payments. Q2 resulted in a $115.9M net loss, including a $53M intangible asset impairment charge, though adjusted EBITDA showed slight improvement to -$11.3M year-over-year. Cost efficiency improved with marketing and consumer care expenses declining 26% and 33% respectively.

GoHealth (NASDAQ: GOCO) has announced significant strategic capital and governance actions to enhance its financial flexibility. The company secured a new $80 million senior secured superpriority term loan facility plus $35 million in roll-up loans to support working capital ahead of the Medicare annual enrollment period.

Key actions include amending the existing credit agreement to waive principal payments through 2026, creating a $250 million debt basket capacity for transformative transactions, and issuing 4.7 million shares of Class A common stock to lenders. The company also appointed three new directors while accepting resignations from three existing board members.

GoHealth (NASDAQ: GOCO), a leading health insurance marketplace and Medicare-focused digital health company, has scheduled an announcement regarding strategic capital and governance actions along with its Q2 2025 financial results for August 7, 2025.

CEO Vijay Kotte and CFO Brendan Shanahan will host a conference call and webcast at 8:00 a.m. ET to discuss these developments. The presentation will be accessible through GoHealth's Investor Relations website, with a replay available after the event.

GoHealth (NASDAQ: GOCO), a health insurance marketplace specializing in Medicare Advantage plans, has secured an amended credit agreement with its lenders. The amendment provides covenant adjustments and extends the company's revolving credit facility maturity to September 30, 2025.

The agreement includes consent for GoHealth to pursue receivables financing, including potential securitization transactions, as part of a broader financing plan. This comprehensive plan aims to address the company's recent going concern position and strengthen its financial foundation for future growth.

CEO Vijay Kotte emphasized that the amendment demonstrates stakeholder support and enables the company to focus on long-term strategic priorities while maintaining its leadership position in the Medicare consumer support sector.

GoHealth Inc. (NASDAQ: GOCO) reported strong financial results for Q1 2025, with net revenues increasing 19.1% year-over-year to $221.0 million. The company demonstrated significant operational improvements, achieving a 40.2% increase in submissions to 303,026 compared to 216,148 in Q1 2024.

The Medicare-focused digital health marketplace provider posted an operating income of $6.7 million, marking a notable turnaround from the previous year's loss. Additionally, Adjusted EBITDA grew by 56.4% to $45.1 million. During the quarter, GoHealth also announced the launch of its new product, GoHealth Protect.

GoHealth (NASDAQ: GOCO) reported strong Q1 2025 financial results with notable improvements across key metrics. The company achieved net revenues of $221.0 million, up 19.1% year-over-year, and reduced its net loss to $9.8 million, a 54.2% improvement from the previous year. Adjusted EBITDA grew 56.4% to $42.1 million. Operational metrics showed significant progress with Submissions increasing 40.2% to 303,026, while Direct Operating Cost per Submission improved 18.4% to $522. The company also launched GoHealth Protect, expanding into guaranteed acceptance life insurance to diversify product offerings and enhance customer relationships. Management emphasized their focus on platform refinement, technology improvements, and strategic investments to drive better business outcomes and consumer experience.